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Summary
SDF-1a (CXCL12) signaling via its receptor, CXCR4,
stimulates T cell chemotaxis and gene expression.
The ZAP-70 tyrosine kinase critically mediates SDF-
1a-dependent migration and prolonged ERK mitogen-
activated protein (MAP) kinase activation in T cells.
However, the molecular mechanism by which CXCR4
or other G protein-coupled receptors activate ZAP-70
has not been characterized. Here we show that SDF-
1a stimulates the physical association of CXCR4 and
the T cell receptor (TCR) and utilizes the ZAP-70 bind-
ing ITAM domains of the TCR for signal transduction.
This pathway is responsible for several of the effects
of SDF-1a on T cells, including prolonged ERKMAP ki-
nase activity, increased intracellular calcium ion con-
centrations, robust AP-1 transcriptional activity, and
SDF-1a costimulation of cytokine secretion. These re-
sults suggest newparadigms for understanding the ef-
fects of SDF-1a and other chemokines on immunity.
Introduction
Stromal cell-derived factor-1a (SDF-1a; CXCL12) is a
member of the superfamily of chemokines that regulates
the growth, survival, adherence, and migration of multi-
ple cell types (Ansel and Cyster, 2001; Campbell and
Butcher, 2000). CXCR4, the receptor for SDF-1a, is
expressed by most T cell subsets. SDF-1a signaling via
CXCR4 results in T cell adhesion, chemotaxis, and
gene expression important for regulating cell-cycle pro-
gression and apoptosis (Thelen, 2001; Suzuki et al.,
2001). Evidence suggests that SDF-1a signaling via
CXCR4 modulates lymphocyte development (Zou et al.,
1998; Hernandez-Lopez et al., 2002), homeostasis (Sa-
wada et al., 1998), and human immunodeficiency virus
type-1 (HIV-1) pathology; however, the molecular mech-
anisms of CXCR4 signaling in T cells are incompletely
understood.
Like other chemokine receptors, CXCR4 is a member
of the G protein-coupled receptor (GPCR) superfamily
and consists of a single polypeptide that spans the mem-
brane seven times. Chemokine receptors signal by acti-
vating Gi-type and other G proteins (Thelen, 2001). SDF-
1a treatment activates multiple downstream signaling
pathways in T cells (Cherla and Ganju, 2001; Chernock
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nte-Manzanares et al., 1999; Sotsios et al., 1999). In par-
ticular, SDF-1a signaling via CXCR4 in T cells results in
prolonged activation of the extracellular signal-regu-
lated kinases, ERK-1 and ERK-2 (ERK) (Tilton et al.,
2000; Kremer et al., 2003). Prolonged ERK activation crit-
ically induces gene expression in other cell types (Mur-
phy et al., 2002), and SDF-1a-mediated ERK pathway ac-
tivation induces multiple genes that regulate T cell signal
transduction, adhesion, cell shape, DNA repair, and ap-
optosis (Suzuki et al., 2001). We have shown that SDF-
1a signaling via CXCR4 in T lymphocytes utilizes both
the tyrosine kinase, ZAP-70, and the scaffold molecule,
SLP-76, to stimulate prolonged ERK activation in T cells
(Kremer et al., 2003). Others have shown that ZAP-70 en-
hances SDF-1a-induced T cell migration (Ottoson et al.,
2001; Soede et al., 1998; Ticchioni et al., 2002). However,
the molecular mechanisms that allow CXCR4 to signal
via ZAP-70 are not clear. The two amino-terminal SH2
domains of ZAP-70 bind the dually tyrosine phosphory-
lated immunoreceptor tyrosine-based activation motif
(ITAM) domains of ITAM-containing receptors (Hatada
et al., 1995; Cambier, 1995). In T cells, the primary
ITAM-containing receptor is the T lymphocyte antigen
receptor (TCR). Ligation of the TCR by a strong agonist
(either TCR mAbs or cognate peptide bound to MHC
class I or II proteins) induces tyrosine phosphorylation
of ITAM domains of the 3, d, g, and z TCR subunits. Phos-
phorylated ITAM domains recruit ZAP-70 (Iwashima
et al., 1994), which mediates signal transduction by
phosphorylating downstream substrates including
SLP-76 and by acting as a scaffold to nucleate signaling
proteins (Kane et al., 2000).
We hypothesized that crosstalk between CXCR4 and
the TCR might permit CXCR4 to utilize ZAP-70 for signal
transduction. Here we show that in response to SDF-1a,
CXCR4 closely associates with the TCR and utilizes TCR
ITAM domains for signal transduction. Structural char-
acterization of the ITAM domain elements suggests
that the ITAM domain mediates CXCR4 signaling by
binding ZAP-70. This signal transduction pathway con-
tributes to the physiologically important actions of
SDF-1a on T cells, substantially enhancing the stimula-
tion of AP-1-dependent transcriptional activity and the
costimulation of TCR-stimulated AP-1 activity and cyto-
kine secretion. These results increase understanding of
the molecular mechanisms responsible for CXCR4 sig-
nal transduction in T cells and suggest potential new
roles for ITAM-containing molecules throughout the im-
mune system as mediators of CXCR4 signaling.
Results
SDF-1a Treatment of T Cells Induces the Close,
Physical Association of CXCR4 and the TCR
To address the possibility that the TCR participates in
CXCR4 signal transduction, we first used confocal mi-
croscopy to visualize Jurkat T cells expressing fluores-
cent fusion proteins of CXCR4 and the TCR-CD3-z
subunit. CXCR4 and TCR-CD3-z fusion proteins were
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214primarily expressed on the cell surface of unstimulated
cells (Figure 1A). SDF-1a treatment redistributed
CXCR4 from the cell surface into intracellular compart-
ments (Figure 1A). Another chemokine, MIP-3b (also
known as CCL19, a ligand for CCR7), did not induce
this response (Figure 1A). SDF-1a induced a portion of
TCR-CD3-z fusion proteins to move and colocalize with
CXCR4 fusion proteins, both on the cell surface and
within small vesicles resembling endosomes (Figure
1A). Similar results were obtained with normal, human,
peripheral blood T cells (PBMC T cells) (data not shown).
Direct stimulation of the TCR via mAb (OKT3) did not alter
the subcellular localization of CXCR4 (Figure 1A). TCR-
CD3-3 fusion proteins also colocalized with CXCR4 in re-
sponse to SDF-1a stimulation (data not shown). Coim-
munoprecipitation further indicated that CXCR4-YFP
copurifies with the TCR-CD3-z subunit (Figure 1B).
To obtain better resolution of the proximity of CXCR4
and the TCR in living cells, we utilized two different fluo-
rescence resonance energy transfer (FRET) methods.
FRET occurs when specific pairs of chromophores
come within approximately 10 nm of each other (Stryer,
1978). First, we assayed FRET between fluorescent fu-
sion proteins of CXCR4 and TCR-CD3-z (Figure 1C). Ju-
rkat T cells expressing both fusion proteins were placed
in a cuvette and excited with 433 nm light, and the emis-
sion spectrum was recorded before (Figure 1D, blue line)
and after (Figure 1D, green line) stimulation with SDF-1a
for 30 min. The reciprocal changes in the YFP emission
peak (528 nm) versus the CFP emission peak (475 nm)
indicated that SDF-1a treatment induced FRET between
the fusion proteins. Confocal microscopy similarly
showed that FRET developed in response to SDF-1a
treatment (Figure 1E). For the second FRET method,
we assayed FRET between endogenous, cell-surface
CXCR4 and TCR molecules that were fluorescently la-
beled via mAbs (Figure 1F). PBMC T cells were labeled
with receptor-specific mAbs, stimulated with SDF-1a,
and assayed for FRET with a flow cytometer. SDF-1a
treatment increased per cell FRET fluorescence, as
shown by the increase in FL3 channel fluorescence
(Figure 1G). SDF-1a also increased the per cell FRET
fluorescence of Jurkat T cells assayed in a similar man-
ner (see Figure S2 in the Supplemental Data available
with this article online). The SDF-1a-induced CXCR4-
TCR FRET signals gradually increased with time after
SDF-1a addition and plateaued after approximately 20
min, were sensitive to either low temperature or a
CXCR4 antagonist, and displayed dose-response rela-
tionships for both Jurkat and PBMC T cells, consistent
with SDF-1a acting by binding to CXCR4 (Figures S1
and S2). No CXCR4-TCR FRET signals were induced
when cells were stimulated with MIP-3b (data not
shown). As a control, we confirmed that cells labeled
with either phycoerythrin (PE) or allophycocyanin
(APC) alone did not show FRET signals, either before
or after SDF-1a treatment (data not shown). As another
control, we confirmed that FRET signals were undetect-
able when a similar approach was used to assay the
proximity of CXCR4 to another abundantly expressed
cell-surface receptor, CD45 (Figure 1H). Similarly, no
FRET signals were detected with this approach to assay
the proximity of the TCR to another chemokine receptor,
CCR7 (data not shown). Together, the results in thissection indicate that SDF-1a treatment causes CXCR4
and the TCR to move into close, physical proximity in
both normal human T cells and the Jurkat T cell line.
Characterization of the CXCR4-TCR Association
Induced by SDF-1a
To address the proportion of the CXCR4-TCR com-
plexes induced by SDF-1a that were located on the cell
surface versus intracellularly (e.g., after endocytosis),
we used an acid wash to remove cell-surface mAbs
(and associated FRET signals) from cells treated with
SDF-1a to generate FRET signals as in Figures 1F and
1G. The acid wash removed approximately half of the
FRET signal associated with the SDF-1a-treated cells,
whereas the rest of the FRET signal was insensitive to
the acid wash (Figure 2A, bottom). Control experiments
confirmed that the acid wash removed the majority of
mAbs bound to CXCR4 and TCR-CD3-3when the recep-
tors were kept on the cell surface by low temperature
(Figure 2A, top). Thus, a substantial proportion of the
CXCR4-TCR FRET signal that arises in response to sub-
sequent SDF-1a treatment derives from within the cell,
presumeably from receptors that have undergone endo-
cytosis. Endocytosis is not by itself sufficient to generate
the FRET signals, however. Inhibitors of either actin po-
lymerization (cytochalasin D) or PI3 kinase activity
(LY294002) did not prevent SDF-1a-induced CXCR4 en-
docytosis (data not shown; Francois and Klotman, 2003).
These drugs partially inhibited the ability of SDF-1a to in-
duce CXCR4-TCR FRET signals (Figure 2B). The forma-
tion of large numbers of CXCR4-TCR complexes might
therefore require one or more cellular polarization events
that are sensitive to these drugs (Vicente-Manzanares
et al., 1999; Sotsios et al., 1999). Finally, we tested the ef-
fects of pertussis toxin (PTX) on CXCR4-TCR associa-
tion. PTX does not inhibit the endocytosis of CXCR4 (For-
ster et al., 1998); however, several downstream CXCR4
signals are sensitive to PTX. PTX had no detectable ef-
fect on the ability of SDF-1a to induce CXCR4-TCR
FRET signals (Figure 2C), even though PTX blocked the
ability of SDF-1a to stimulate downstream ERK activa-
tion (Figure 2D). The results in this section are consistent
with SDF-1a treatment bringing CXCR4 into close prox-
imity with the TCR via a cellular polarization event.
SDF-1a Signal Transduction Requires
TCR ITAM Domains
We next asked whether SDF-1a signal transduction via
CXCR4 was altered by CXCR4 associating with the
TCR. The mutant Jurkat T cell line, JRT3, is deficient in
expression of the TCR-b subunit and is consequently de-
ficient in cell-surface TCR as compared to the parental
Jurkat cell line (Figure 3A, left; Ohashi et al., 1985; Weiss
and Stobo, 1984). Nevertheless, JRT3 cells express nor-
mal levels of cell-surface CXCR4 (Figure 3A, right). SDF-
1a stimulation of T cells normally results in prolonged
ERK activation, defined as elevated ERK activity after
8–12 min of SDF-1a stimulation (Figure 3B; Kremer
et al., 2003; Tilton et al., 2000). Here we found that
TCR-b-deficient cells displayed a substantial defect in
SDF-1a-dependent ERK activation at 8 and 10 min
(Figure 3B). ERK activation in TCR-b-deficient Jurkat T
cells after 8 or 10 min of SDF-1a stimulation was signifi-
cantly lower than in normal Jurkat T cells (44% 6 15%
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215Figure 1. SDF-1a Treatment Induces the Movement and Close, Physical Association of CXCR4 and the TCR
(A) Confocal microscopy of CXCR4-YFP (green) and/or TCR-CD3-z-RFP (red) fusion proteins in live, Jurkat T cells. The left panels show cells
expressing CXCR4-YFP before and after 30 min stimulation with SDF-1a, TCR-CD3 mAb (OKT3), or MIP-3b. The arrowhead denotes intracellular
CXCR4-YFP fluorescence. The right panels show a single cell expressing both CXCR4-YFP (green) and TCR-CD3-z-RFP (red), before and after
30 min stimulation with SDF-1a.
(B) Jurkat T cells expressing CXCR4-YFP were stimulated with SDF-1a for 20 min. TCR-CD3-zwas immunoprecipitated with either specific (right
lane) or control (left lane) immunoglobulin. Copurifying CXCR4-YFP was detected by immunoblotting with anti-YFP (upper gel). As a control, the
same blot was stripped and reprobed with anti-TCR-CD3-z (lower gel). Results are representative of three independent experiments.
(C) Cartoon depicting FRET between fluorescent fusion proteins of CXCR4 and the TCR.
(D) Fluorescence spectrometer assay of CXCR4-TCR FRET in Jurkat T cells via the approach in (C). The fluorescence emission spectra of the
same cells in response to 433 nm excitation before (blue line) and after (green line) 30 min of SDF-1a treatment are shown.
(E) Confocal microscope assay of CXCR4-TCR FRET in Jurkat T cells via an approach similar to (C). CXCR4-CFP (blue), TCR-CD3-z-YFP (yellow),
and FRET fluorescence (red) of a single, live Jurkat T cell before and after SDF-1a treatment are shown.
(F) Cartoon depicting FRET between endogenous CXCR4 and TCR receptors linked to fluorophores via mAbs.
(G) Flow cytometer assay of FRET of endogenous CXCR4 and TCR on normal human T cells via the approach in (F). Both CXCR4-PE and TCR-
CD3-3-APC mAb were bound to the cell-surface CXCR4 and TCR-CD3-3, and after 20 min stimulation with either SDF-1a or water (vehicle), FRET
was assayed by flow cytometry.
(H) No FRET was observed between CXCR4 and CD45 of Jurkat T cells via an approach similar to (F). Results are representative of 3–15 inde-
pendent experiments.
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216Figure 2. Characterization of the CXCR4-TCR Association Induced by SDF-1a
(A) Top: Results of control samples in which cells were stained with CXCR4-PE and TCR-CD3-3-APC mAb as in Figure 1F, stimulated with SDF-1a
for 30 min and kept at 4C to prevent receptor endocytosis, and then analyzed for mAb bound to CXCR4 or TCR-CD3-3 before (solid red histo-
grams) and after (blue histograms) an acid wash designed to remove cell-surface mAbs. Bottom: Results of experimental samples in which cells
were stained with CXCR4-PE and TCR-CD3-3-APC mAb as in Figure 1F, stimulated with SDF-1a for 30 min at 37C, and analyzed for FRET before
and after acid wash designed to remove cell-surface mAbs and consequently FRET signals.
(B) Jurkat T cells were pretreated with inhibitors as indicated, and then the CXCR4-TCR FRET of endogenous receptors in response to SDF-1a
was assayed as in Figure 1F. Cyto D., cytochalasin D. Histograms show representative results; the bar graph shows the mean SDF-1a-dependent
FRET response 6 SEM for 3–4 experiments as a % of controls analyzed the same day; *significantly different from controls (p < 0.05).
(C) Jurkat T cells were pretreated with either nothing, pertussis toxin (PTX), or an inactive control toxin (PTX-B). The CXCR4-TCR FRET of en-
dogenous receptors in response to SDF-1a was then assayed as in Figure 1F. A representative experiment showing histograms of FRET signals
of PTX-treated cells is shown.
(D) PTX-pretreated T cells were stimulated with SDF-1a and assayed for active, phosphorylated ERK by immunoblotting (upper gel). The same
blots were stripped and immunoblotted with anti-total ERK2 as a control (lower gel).of control responses at 8 min, p = 0.03, n = 4; and 42%6
9% of control responses at 10 min, p = 0.01, n = 4). This
SDF-1a signaling defect arises from the TCR-b defi-
ciency, because JRT3 cells stably reconstituted with
TCR-b (creating the PF2.4 cell line) activated ERK nor-
mally in response to SDF-1a (Figures 3A and 3B). Indeed,
SDF-1a-dependent ERK activation in the TCR-b-recon-
stituted PF2.4 cell line was not markedly different from
that of normal Jurkat T cells (p = 0.80 and p = 0.63 for
responses at 8 and 10 min, respectively; n = 4). Thus,
SDF-1a signal transduction resulting in prolonged ERK
activation requires expression of TCR-b and correlates
with expression of the TCR at the cell surface.
We next asked whether SDF-1a signaling requires the
ITAM domains of the TCR. For this purpose, we utilized
constructs encoding CD8-CD3-z chimeras consisting
of the extracellular and transmembrane regions ofCD8a fused to the cytoplasmic region of TCR-CD3-z,
which normally contains three ITAM domains (Figure
3C). Transient expression in TCR-b-deficient cells of
CD8-CD3-z (‘‘wt’’ or ‘‘wild-type’’ in Figures 3C–3E) re-
stored SDF-1a-mediated ERK activation (Figures 3D
and 3E). In contrast, the CD8-CD3-z construct missing
most of the TCR-z portion including all three ITAM do-
mains (‘‘STOP’’) failed to rescue SDF-1a-mediated ERK
activation (Figure 3E). The CD8-CD3-z construct with
each ITAMs’ critical tyrosines modified by point mutation
(‘‘6F’’) also failed to rescue SDF-1a-mediated ERK acti-
vation, a result specifically indicating the critical impor-
tance of the ITAM tyrosines in mediating SDF-1a signal-
ing. Because ZAP-70 binds to ITAM domains only when
both tyrosines are phosphorylated, we determined
whether both ITAM tyrosines were required for SDF-1a
signaling. SDF-1a-mediated ERK activation was
CXCR4 Signals via the TCR
217Figure 3. SDF-1a Uses TCR ITAM Domains to Stimulate Prolonged ERK Activation
(A) Flow cytometric analyses of the cell-surface expression of TCR-CD3-3 and CXCR4 on the Jurkat T cell line, the TCR-b-deficient JRT3 cell line,
and JRT3 stably reconstituted with TCR-b (PF2.4).
(B) The indicated cell lines were stimulated with SDF-1a, then lysed and assayed for active ERK as in Figure 2D. Results are representative of four
independent experiments.
(C) Cartoon of CD8-CD3-z fusion proteins showing the CD8a extracellular domain (black), the CD8a transmembrane region (TM), and TCR-z
cytoplasmic domains that are either wild-type (wt), truncated (STOP), or with ITAM tyrosines (Y) mutated to phenylalanines (F). Each YY denotes
one ITAM domain.
(D) TCR-b-deficient (JRT3) Jurkat T cells were transiently transfected with the indicated plasmids, stimulated with SDF-1a, and then assayed for
active ERK as in Figure 2D.
(E) TCR-b-deficient (JRT3) Jurkat T cells were transiently transfected with the indicated plasmids, stimulated with SDF-1a, and then assayed for
active ERK by flow cytometry. Each bar shows the mean % of CD8-CD3-z-expressing cells with elevated phosphorylated ERK in response to
SDF-1a 6 SEM for six independent experiments; *significantly different from vector control or STOP construct results (p < 0.05).defective in cells reconstituted with ‘‘3F,’’ ‘‘4F,’’ or ‘‘4OF’’
constructs, all of which have all three of their TCR-z ITAM
domains mutated (Figure 3E). In contrast, the ‘‘2F’’ con-
struct, which has one intact ITAM domain, restored
SDF-1a-mediated ERK activation in a manner indistin-
guishable from the wt CD8-z chimeric protein (pR 0.5).
Together, these results indicate that SDF-1a signaling
leading to prolonged ERK activation requires expression
of the TCR and characterize structural features of the
ITAM domain that are required for this novel signal trans-
duction pathway.SDF-1a Stimulation of Robust Ras Activation
Requires Both the TCR and ZAP-70
We previously showed that SDF-1a signaling leading to
prolonged ERK activation requires the expression of
ZAP-70 (Figure 4A; Kremer et al., 2003). To gain further
insight into this signaling pathway, we examined the
role of Ras. SDF-1a treatment of both Jurkat and
PBMC T cells stimulated similar amounts of active, GTP
bound Ras (Figure 4B). SDF-1a-dependent Ras activa-
tion was deficient in TCR-b-deficient cells as compared
to either wild-type Jurkat cells or TCR-b-reconstituted
Immunity
218Figure 4. Constitutively Tyrosine Phosphorylated TCR and ZAP-70 Mediate Robust Ras Activation in Response to SDF-1a
(A) Wild-type (wt) Jurkat T cells or ZAP-70-deficient (P116) Jurkat T cells were stimulated for 8 min with SDF-1a, then assayed for active ERK as in
Figure 2D.
(B) Wild-type Jurkat T cells or PBMC T cells were stimulated for 8–10 min with SDF-1a, and then active, GTP bound Ras (RAS-GTP) was detected
by affinity purification and immunoblotting with anti-Ras (upper gel). As a control, whole-cell lysates were immunoblotted for total Ras (lower gel).
(C and D) Ras activation of the indicated cell lines, determined as in (B).
(E) The indicated cell lines were stimulated for 2 min with either crosslinked TCR mAb (CD3) or SDF-1a, and then phospho-tyrosine-containing
proteins were immunoprecipitated with 4G10 mAb and immunoblotted with anti-ZAP-70.
(F) Jurkat T cells were stimulated as in (E), and then ZAP-70 was immunoprecipitated and immunoblotted with anti-phosphotyrosine (4G10; up-
per gel) or anti-ZAP-70 (lower gel).
(G) Jurkat T cells were stimulated as in (E), and then TCR-zwas immunoprecipitated and immunoblotted with anti-phosphotyrosine (4G10; upper
gel) or anti-TCR-z (lower gel).
(H) Densitometric quantitation of three independent experiments as in (G) 6 SEM. Results in (A)–(H) are representative of 3–6 experiments.cells (Figure 4C). SDF-1a-mediated Ras activation was
also deficient in ZAP-70-deficient Jurkat T cells, and
this defect was restored by reconstituting ZAP-70 (Fig-
ure 4D). Thus, SDF-1a signaling via the TCR and ZAP-
70 enhances Ras activation in addition to prolonging
ERK activation.
SDF-1a Signaling Occurs via Constitutively Tyrosine
Phosphorylated TCR and ZAP-70
We next asked whether constitutively tyrosine phos-
phorylated ITAM domains or inducibly tyrosine phos-
phorylated ITAM domains participate in mediating
SDF-1a signal transduction. Constitutively tyrosine
phosphorylated ZAP-70 was easily detected in unstimu-
lated, wild-type Jurkat cells (Figure 4E). Constitutively
tyrosine phosphorylated ZAP-70 was not seen in unsti-
mulated cells of the TCR-b-deficient cell lines, suggest-
ing that it requires cell-surface TCR expression. SDF-1a
treatment failed to increase the tyrosine phosphoryla-
tion of ZAP-70. In contrast, inducible tyrosine phosphor-
ylation of ZAP-70 was easily detected after direct liga-
tion of the TCR via specific mAb (CD3) (Figure 4E).
SDF-1a also failed to elevate the amounts of ZAP-70
phosphorylated on tyrosine 493, a site that is phosphor-
ylated when the kinase is active (Chan et al., 1995; data
not shown). Finally, SDF-1a did not detectably alter tyro-
sine phosphorylation of either TCR-z (Figures 4F–4H) or
TCR-3 (data not shown). These results suggest thatSDF-1a signal transduction proceeds via constitutively
tyrosine phosphorylated, rather than inducibly tyrosine
phosphorylated, TCR and ZAP-70.
The TCR and ZAP-70 Are Required for Robust AP-1
Transcriptional Activity and [Ca2+]i Mobilization
Prolonged ERK activation prolongs the half-life of AP-1
subunits (Murphy et al., 2002). SDF-1a significantly stim-
ulated AP-1-dependent transcriptional activity in Jurkat
T cells by approximately 2.5-fold as compared to unsti-
mulated cells (p < 0.05) (Figure 5A). This action of SDF-
1a was inhibited by PD098059, an inhibitor of MEK-1
and downstream ERK. The TCR-b-deficient Jurkat T
cells displayed deficient SDF-1a-mediated activation of
AP-1 transcriptional activity, but this was restored to
normal amounts after reconstitution with TCR-b (p %
0.01) (Figure 5B). SDF-1a stimulation of AP-1 transcrip-
tional activity also required ZAP-70 (Figure 5C). These re-
sults indicate that SDF-1a signaling via the TCR and
ZAP-70 increases AP-1 transcriptional activity. We also
asked whether the TCR might participate in SDF-1a-me-
diated [Ca2+]i mobilization, because we previously
showed that this response requires ZAP-70 (Kremer
et al., 2003). The TCR-b-deficient Jurkat T cells displayed
deficient SDF-1a-mediated [Ca2+]i mobilization as com-
pared to the TCR-sufficient parental cell line (Figure
5D). Together, the results in this section demonstrate
that SDF-1a signaling via the TCR and ZAP-70 is required
CXCR4 Signals via the TCR
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(A) Jurkat T cells were transiently transfected with an AP-1 luciferase reporter construct, pretreated with either vehicle (DMSO) or a MEK-1 in-
hibitor (PD098059; PD), and stimulated as indicated, and transcriptional activity of AP-1 was assayed by measuring luciferase activity; R.L.U.,
relative light units 6 SD (n = 3).
(B and C) AP-1 transcriptional activities of the indicated cell lines, as determined in (A).
(D) Flow cytometric [Ca2+]i assays of the indicated cell lines in response to SDF-1a (arrow). Fluor. Ratio, the 405 nm:495 nm fluorescence ratio that
correlates with [Ca2+]i. Results are typical of three independent experiments.both for robust AP-1 transcriptional activity and [Ca2+]i
mobilization.
SDF-1a Costimulation of TCR-Stimulated
T Cells Selectively Enhances Expression
of CD69, IL-10, and IL-2
SDF-1a is abundant within the lymph nodes (Muller et al.,
2001), where the immune activation of naive T cells oc-
curs via ligation of the TCR. We therefore addressed
the effects on T cell activation of simultaneously ligating
both CXCR4 and the TCR. Costimulation with SDF-1a
and CD3 mAb significantly enhanced AP-1-dependent
transcription by approximately 7.3-fold as compared to
unstimulated cells (p < 0.05), a response approximately
2.7-fold higher than that induced by either SDF-1a or
CD3 mAb alone (Figure 6A). In contrast to AP-1, neither
NF-AT (Figure 6B) nor NF-kB (Figure 6C) -dependent
transcriptional activity was affected by either SDF-1a
stimulation or costimulation. We next asked whether
the selective SDF-1a costimulation of AP-1 regulates
downstream gene expression. PBMC T cells markedly
elevated their per cell cell-surface expression of CD69
when costimulated by SDF-1a (Figures 6D and 6E). In
contrast to its effects on CD69, SDF-1a costimulation
had no effect on the cell-surface expression of CD25
(Figure 6F). SDF-1a costimulation increased the pro-
portion of TCR-stimulated T cells expressing IL-10
(Figure 6G), as well as the amount of IL-10 secreted
into the supernatants (Figure 6H). SDF-1a costimulation
also significantly increased the number of TCR-stimu-lated T cells expressing IL-2 (Figures 6I and 6J)
(p < 0.05). In contrast to its effects on IL-10 and IL-2
expression, SDF-1a costimulation failed to consis-
tently increase the expression of IFN-g by TCR- or
TCR+CD28-stimulated PBMC T cells (data not shown).
Thus, SDF-1a costimulation selectively enhances TCR-
mediated activation of the AP-1 transcription factor
and the expression of CD69, IL-2, and IL-10.
Model of SDF-1a Signaling via CXCR4 and the TCR
Based on our results, we propose the model shown in
Figure 7. SDF-1a binding to CXCR4 induces its associa-
tion with the TCR, via a mechanism involving reorganiza-
tion of the actin cytoskeleton and PI3 kinase activity. Co-
localization of the receptors permits CXCR4 to signal via
pre-existing, constitutively phosphorylated TCR-ZAP-
70 complexes, leading to more robust Ras activation in
response to SDF-1a. Both TCR and ZAP-70 are required
for SDF-1a to stimulate prolonged ERK activation. Pro-
longed ERK activation leads to AP-1 transcriptional ac-
tivation, which mediates gene expression in response to
SDF-1a alone and which also mediates SDF-1a’s ability
to selectively costimulate cytokine gene expression by
TCR-stimulated T cells.
Discussion
We describe here close, physical interactions between
CXCR4 and the TCR that are formed in response to
stimulating CXCR4 with SDF-1a. Two complementary
Immunity
220Figure 6. SDF-1aCostimulation of TCR-Stimulated T Cells Selectively Increases AP-1-Dependent Transcriptional Activity and Enhances Expres-
sion of CD69, IL-10, and IL-2
(A–C) Jurkat T cells were transiently transfected with the indicated reporter constructs and assayed for luciferase activity as in Figure 5A (n = 3).
(D) PBMC T cells were stimulated in vitro and assayed for CD69 by flow cytometry.
(E) Summary of results as in (D) for five different PBMC donors; M.F.I., mean fluorescent index.
(F) Summary of CD25 expression on human T cells for three different PBMC donors.
(G) PBMC T cells were stimulated in vitro and assayed for IL-10 by intracellular cytokine staining.
(H) Summary of IL-10 secreted by three different PBMC donors.
(I) PBMC T cells were stimulated in vitro and assayed for IL-2 by intracellular cytokine staining.
(J) Summary of IL-2 production for six different PBMC donors.
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221Figure 7. Model of SDF-1a Signaling via
CXCR4 and the TCR
SDF-1a binding to CXCR4 induces its associ-
ation with the TCR via a mechanism involving
reorganization of the actin cytoskeleton and
PI3 kinase activity. The association of
CXCR4 with the TCR permits CXCR4 to signal
via pre-existing, constitutively phosphory-
lated TCR-ZAP-70 complexes, leading to
more robust Ras and prolonged ERK activa-
tion in response to SDF-1a. Prolonged ERK
activation enhances AP-1 transcriptional ac-
tivity, which mediates gene expression in
response to SDF-1a alone and which also
mediates SDF-1a’s ability to selectively costi-
mulate cytokine expression by TCR-stimu-
lated T cells.fluorescence resonance energy transfer (FRET) ap-
proaches and coimmunoprecipitation were used to
show that SDF-1a treatment induces the close associa-
tion of CXCR4 with both TCR-CD3-z and TCR-CD3-3
subunits. The FRET method used to measure CXCR4-
TCR-CD3-3 interactions additionally allows us to con-
clude that the interacting receptor molecules were
originally located on the cell surface. FRET occurs
when specific pairs of chromophores come within ap-
proximately 10 nm of each other (Stryer, 1978). Because
the vast majority of cell-surface TCR-CD3-3 and TCR-
CD3-z subunits reside within the TCR holoreceptor
(Alarcon et al., 1988), our results indicate that SDF-1a
treatment induces the close and perhaps direct associ-
ation of CXCR4 and the TCR. We further show here that
Ras activation, [Ca2+]i mobilization, and the prolonged
ERK activation previously noted to be typical of SDF-
1a signaling via CXCR4 in T cells (Kremer et al., 2003; Til-
ton et al., 2000) depend on expression of the TCR b-sub-
unit and correlate with cell-surface expression levels of
the TCR. Together, our results indicate that the physical
interaction between CXCR4 and the TCR functionally
modulates SDF-1a signaling via CXCR4 in T cells.
The TCR has not previously been shown to heterodi-
merize with CXCR4 or any other GPCR; therefore, we an-
alyzed the molecular mechanisms responsible for this
signal transduction pathway. The TCR signals via its cy-
tosolic ITAM domains binding the tyrosine kinase, ZAP-
70 (Hatada et al., 1995; Iwashima et al., 1994; Cambier,
1995). We have shown that ZAP-70 expression is re-
quired for SDF-1a to stimulate prolonged ERK activation
(Kremer et al., 2003), and we show here that ZAP-70 is
also required for SDF-1a to stimulate robust Ras activa-
tion. We also show here that plasma membrane localiza-
tion of the intracellular region of the TCR-CD3-z subunit,
which contains three ITAM domains, is sufficient to re-
store SDF-1a-dependent prolonged ERK activation incells deficient in TCR expression. In addition, we show
that the mutation of one or both ITAM tyrosines abro-
gates the ability of the ITAM domain to participate in
SDF-1a signaling. To bind ZAP-70, an ITAM domain
must be phosphorylated on both of its canonical tyro-
sine residues (Iwashima et al., 1994). Thus, our results
indicate that SDF-1a signals via the TCR ITAM domains,
most likely because these domains bind ZAP-70. These
results support previous reports that tyrosine kinases
critically participate in CXCR4 signal transduction in
T cells and suggest that, in addition to ZAP-70, the Src
family tyrosine kinase Lck participates in CXCR4 signal-
ing. Indeed, CXCR4 has previously been shown to acti-
vate Lck (Ganju et al., 1998), and Lck can phosphorylate
TCR ITAM domains (Iwashima et al., 1994).
Our results as well as previous studies (Nanki and Lip-
sky, 2000; Molon et al., 2005) make clear that CXCR4
signaling does not simply recapitulate TCR signaling.
For example, although CXCR4 stimulates the ERK path-
way to a similar extent as does the TCR, the TCR but not
CXCR4 also activates NF-kB and NF-AT luciferase re-
porter constructs. It is therefore perhaps not surprising
that in contrast to direct stimulation of the TCR, our re-
sults indicate that CXCR4 signaling via the TCR does
not detectably increase the phosphorylation of either
the TCR or ZAP-70. Because we were unable to detect
inducible tyrosine phosphorylation of either the TCR or
ZAP-70 in response to CXCR4, and because we de-
tected constitutively phosphorylated and associated
TCR and ZAP-70 within unstimulated cells, we suggest
that CXCR4 signaling, in contrast to TCR signaling, uti-
lizes pre-existing constitutively tyrosine phosphorylated
TCR-ZAP-70 complexes. Jurkat T cells as well as normal
resting T cells and murine thymocytes have previously
been noted to contain low but detectable amounts of
constitutively associated TCR and ZAP-70 (Chan
et al., 1991; van Oers et al., 1994; Kersh et al., 1998).
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creases the tyrosine phosphorylation of a subset of
TCR and ZAP-70 molecules that we were unable to de-
tect. Our results further suggest that SDF-1a treatment
induces the association of CXCR4 and TCR molecules
detectable at the cell surface and within intracellular
compartments via a mechanism partly sensitive to inhib-
itors of cellular polarization. GPCRs heteromultimerized
with receptor tyrosine kinases have been shown to pro-
mote activation of endosomal Ras-ERK pathways in
other cell types (Mor and Philips, 2006). It is therefore
possible that the subcellular localization of CXCR4-
TCR-ZAP-70 complexes mediates more robust and pro-
longed activation of Ras and ERK.
CXCR4 signaling via this TCR- and ZAP-70-dependent
pathway contributes to several physiological effects of
SDF-1a on T cells. First, expression of both the TCR
and ZAP-70 is required for robust AP-1-dependent tran-
scriptional activity in response to SDF-1a. AP-1 is most
likely activated in response to prolonged ERK activity,
because AP-1 activation was abrogated by a MEK-1 in-
hibitor and because prolonged ERK activity prolongs
the half-life of AP-1 subunits (Murphy et al., 2002).
SDF-1a signaling via the TCR would therefore be ex-
pected to mediate the transcription of AP-1-dependent
gene products during the migration of resting T cells
through the lymph nodes, bone marrow, and other ana-
tomical locations that constitutively express SDF-1a
(Muller et al., 2001). This SDF-1a signaling pathway
may be important for promoting the survival of resting
T cells, because SDF-1a treatment of a T cell line stimu-
lates the expression of several antiapoptotic gene prod-
ucts via the MEK-1-ERK pathway (Suzuki et al., 2001).
SDF-1a signaling via the TCR may also modulate thymo-
cyte development, which critically depends on the Ras-
ERK pathway (Hernandez-Lopez et al., 2002). Second,
our results indicate that the AP-1 activity induced via
this novel CXCR4-TCR signaling pathway mediates
SDF-1a costimulation of cytokine secretion by activated
T cells. SDF-1a selectively costimulates the TCR-stimu-
lated expression of CD69, IL-10, and IL-2, which are
AP-1 dependent (Jain et al., 1995; Wang et al., 2005;
D’Ambrosio et al., 1994). IFN-g costimulation may criti-
cally depend on the relative timing of the SDF-1a and
TCR signals, since while SDF-1a costimulatory effects
on IFN-g production failed to reach significance in our
experiments, SDF-1a was previously reported to costi-
mulate IFN-g production by CD4+ T cells when added 2
hr prior to TCR ligation (Nanki and Lipsky, 2000) and after
APC-mediated T cell stimulation (Molon et al., 2005). A
remarkable feature of SDF-1a costimulation is its selec-
tivity, which corresponds with SDF-1a selectively en-
hancing the AP-1, but not NF-kB or NF-AT, -dependent
transcription of either TCR- or TCR+CD28-stimulated T
cells. Selective costimulation of cytokine secretion may
allow SDF-1a to promote T cell tolerance in two ways:
by enhancing T cell activation within SDF-1a-rich lymph
nodes as opposed to SDF-1a-poor tissues and by bias-
ing against Th1 responses by enhancing the production
of IL-10.
Our results broaden paradigms for understanding
CXCR4 and GPCR signal transduction in immune cells.
CXCR4 signal transduction in other cell types is likely
to be modulated and regulated by other cell-surfacereceptors that contain ITAM domains, including the B
cell receptor, the Fc-3 receptor I, and NK activating re-
ceptors that signal via DAP-12 (Cambier, 1995). Signal-
ing by CXCR4 that depends on coexpression of an
ITAM-containing protein may help explain, for example,
the different functions of CXCR4 at different stages of B
cell development (D’Apuzzo et al., 1997). In addition, our
results suggest that other GPCR may, like CXCR4, be
capable of utilizing ITAM-containing receptors for signal
transduction. Thus, among immune cells that express
ITAM-containing receptors and either ZAP-70 or its ho-
molog, SYK, the roles and functions of CXCR4 and other
chemokine receptors and GPCRs may be distinct as
compared to other cell types.
Experimental Procedures
Cells
PBMC were isolated from healthy volunteers with approval of the
Mayo IRB. T cells were purified with the RosetteSep T cell enrich-
ment cocktail (Stem Cell Technologies, Canada). Jurkat T cell lines
were maintained as described (Kremer et al., 2003). R. Abraham
(Burnham Institute, La Jolla, CA) provided ZAP-70-deficient Jurkat
cells (P116) and P116 cells stably reconstituted with ZAP-70 (P116-
C40) (Williams et al., 1998). Jurkat cells deficient in TCR-b (JRT3)
were obtained from the American Type Culture Collection (Rockville,
MD). JRT3 stably reconstituted with TCR-b (PF-2.4) was a gift of A.
Weiss (University of California, San Francisco, CA) (Ohashi et al.,
1985; Weiss and Stobo, 1984).
Reagents and Stimulation Conditions
Unless otherwise indicated, stimulations were at 37C with 53 1028
M SDF-1a (R&D Systems, Minneapolis, MN). TCR ligation was
achieved by crosslinking TCR mAbs: for reporter assays and cyto-
kine production assays, the TCR was ligated via plate bound 1 mg/
ml CD3 mAb (OKT3, Ortho Biotech, Bridewater, NJ); for biochemical
assays, OKT3 was crosslinked as described (Kremer et al., 2003).
Where indicated, cells were pretreated for 5 min with the CXCR4 an-
tagonist, CXCR4-4-2 (Tarasova et al., 1999), 16 hr with 100 ng/ml PTX
or PTX-B (RBI/Sigma, Natick, MA), 90 min with 50 mM PD098059
(Sigma, St. Louis, MO), 60 min with 10 mM cytochalasin D, or 16 hr
with 50 mM LY294002 (Calbiochem).
Confocal FRET Imaging and Fluorescence Spectroscopic
Analysis of CXCR4 and TCR Fluorescent Fusion Proteins
Transiently Expressed in Live Cells
cDNA encoding human CXCR4, TCR-CD3-z, and TCR-CD3-3 was
amplified by PCR (primers available upon request) and subcloned
into pEYFP-N1, pDsRed2-N1, or pECFP-N1 (Clontech, Mountain
View, CA). Plasmids were transiently transfected into Jurkat cells
(Kremer et al., 2003) or purified human T cells (Bell et al., 2001), as de-
scribed. The same, live cells were imaged with a Model 510 inverted
laser scanning confocal microscope with a 1003 objective and
a 37C heated stage (Carl Zeiss, Germany) 6 SDF-1a for 30 min.
Confocal FRET assays employed respective excitation lasers and
emission filters of 440 nm and 455–525 nm (for CFP), 532 nm and
560–675 nm (for YFP), and 440 nm and LP550 nm (for FRET). Jurkat
T cells expressing fluorescent fusion proteins individually were em-
ployed as controls; no FRET signals were detected in these control
samples (Figure S3). Spectroscopic analysis of steady-state fluores-
cence of cells in a quartz cuvette in response to 433 nm excitation
before and after 30 min of SDF-1a stimulation (SPEX Fluorolog Spec-
trofluorophotometer, Model 1680-0.22, SPEX Industries, Edison, NJ)
confirmed that SDF-1a-induced increases in FRET fluorescence
were accompanied by decreased CFP fluorescence (Figure 1D).
Cells expressing either one or the other of the fluorescent fusion pro-
teins were employed as controls.
FRET of Fluorescent mAbs Bound to Endogenous,
Cell-Surface CXCR4 and TCR-CD3-3
Cells were incubated with excess CXCR4 mAb conjugated to PE
(Clone #44717; R&D Systems) and excess CD3-3 mAb conjugated
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223to APC (Clone #UCHT1; Pharmingen, San Diego, CA) for 20 min at
4C, then washed in cold FACS buffer without azide (HBSS with 10
mg/ml BSA and 10 mM HEPES [pH 7.5]). Where indicated, CD45
mAb conjugated to APC (Pharmingen, San Diego, CA) was used in-
stead of CD3-3-APC mAb. Stained cells were either kept on ice or
incubated at 37C 6 SDF-1a. FRET was assayed by flow cytometry
either immediately or after fixation in 2% paraformaldehyde/PBS.
Flow cytometry utilized a dual-laser (488 nm Ar and 635 nm He-Ne)
FACS Caliber (Becton Dickinson, Franklin Lakes, NJ), as described
(Batard et al., 2002). Excitation/emission windows were 488 nm/
530 6 15 nm (FL1), 488 nm/585 6 21 nm (FL2), 488 nm/>670 nm
(FL3), and 635 nm/661 6 8 nm (FL4). Where indicated, an acid
wash was employed as follows. Cells were prepared as above for
FRET analysis, stimulated with SDF-1a for 30 min to induce FRET
signals, then incubated at 4C for 5–10 min either in cold FACS buffer
or in 20 mM HCl/HBSS (pH 2.0). After washing, the cells were resus-
pended in cold FACS buffer, fixed, and analyzed for FRET signals.
Coimmunoprecipitation of CXCR4/TCR Complexes
Jurkat T cells were transiently transfected with a plasmid encoding
the CXCR4-YFP fusion protein. Cells were stimulated at 37C with
SDF-1a for 20 min, then lysed in Buffer A (150 mM NaCl, 20 mM
TRIS-Cl [pH 7.4], 5 mM EDTA, 1 mM CaCl2, 1% Triton X-100, 5%
glycerol, 10 mM NaF, and 1 mM sodium orthovanadate). TCR-
CD3-z was immunoprecipitated with anti-CD3-z-agarose or control
IgG agarose (Santa Cruz Biotechnology, Santa Cruz, CA), washed
with Buffer A, and analyzed by immunoblotting with anti-YFP (Clon-
tech, Mountain View, CA) or anti-TCR-CD3-z.
Assays of Active Ras and Active, Phosphorylated
ERK1 and ERK2
Cells were stimulated as indicated, and levels of active, GTP bound
Ras were assayed with an affinity purification kit (Upstate; Waltham,
MA). Active ERK was assayed by immunoblotting as described
(Kremer et al., 2003). Where indicated, JRT3 cells were transiently
transfected with plasmids encoding chimeric CD8-CD3-z proteins
(gifts of P. Allen, Washington University, St. Louis, MO) and stimu-
lated with SDF-1a, and ERK was assayed by flow cytometry of fixed,
permeabilized cells stained with anti-CD8 and phospho-specific
p44/p42 ERK1 and ERK2 (Thr-202/Tyr-204) mAb conjugated to either
Alexa Fluor-488 or Alexa Fluor-647 (BD Pharmingen). Gating was
used to compare ERK activities of cells expressing similar levels of
CD8.
Immunoprecipitation and Immunoblot Analyses
of Tyrosine Phosphorylated Proteins
Cells were stimulated as indicated and lysed as described (Kremer
et al., 2003), and endogenous signaling proteins were immunopre-
cipitated with P-Tyr mAb 4G10 (Upstate; Waltham, MA) or anti-
TCR-z (Santa Cruz Biotechnology). Proteins were separated by
SDS-PAGE and analyzed by immunoblotting with anti-P-Tyr mAb
(4G10), anti-ZAP-70-pTyr-493 (Cell Signaling Technology, Danvers,
MA), or anti-total ZAP-70 (Cell Signaling Technology). Quantification
was via autoradiography and densitometry (AMBIS; Molecular Dy-
namics, Sunnydale, CA).
Reporter Assays, [Ca2+]i Analysis, and Assays of Cytokine
and Cell-Surface Marker Expression
Assays of NF-AT- or NF-kB-dependent transcriptional activity in
transiently transfected cells were performed as described (Hedin
et al., 1997). The AP-1 reporter plasmid (gift of D. Billadeau, Mayo
Clinic, Rochester, MN; Cao et al., 2002) was used in a similar manner.
[Ca2+]i assays were performed as described (Kremer et al., 2003).
The Cytoperm/Cytofix intracellular cytokine staining kit (BD Phar-
mingen, San Diego, CA) was used after cells were stimulated for
24 hr (for CD69 and IL-10 detection) or 6 hr (for CD25 and IL-2).
Secreted IL-10 was assayed after 24 hr by ELISA (BD Pharmingen).
Supplemental Data
Three Supplemental Figures can be found with this article online at
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